Effects of an endothelin receptor antagonist, Macitentan, on right ventricular substrate utilization and function in a Sugen 5416/hypoxia rat model of severe pulmonary arterial hypertension

Katarzyna Drozd(University of Ottawa), Lisa Mielniczuk(University of Ottawa), Robert A. deKemp(University of Ottawa), Julia Petryk(Ottawa Hospital), Stephanie Thorn(University of Ottawa), Rob Beanlands(University of Ottawa), Duncan J. Stewart(University of Ottawa), Ali Ahmadi(Shahrekord University of Medical Sciences), Baohua Jiang(Ottawa Hospital), Yupu Deng(Ottawa Hospital), Jean N. DaSilva(Centre Hospitalier de l’Université de Montréal)
Journal of Nuclear Cardiology
September 29, 2016
10.1007/s12350-016-0663-4
Cited by 26

Related Papers

Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021
|The Lancet|2023|4.5k
Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants
|The Lancet|2021|3.8k
Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019
|JAMA Oncology|2021|2.1k
Global burden of chronic respiratory diseases and risk factors, 1990–2019: an update from the Global Burden of Disease Study 2019
|EClinicalMedicine|2023|790
Impaired Myocardial Flow Reserve on Rubidium-82 Positron Emission Tomography Imaging Predicts Adverse Outcomes in Patients Assessed for Myocardial Ischemia
|Journal of the American College of Cardiology|2011|602